The TEASE-1 trial reveals gildeuretinol's potential to reduce vision loss in Stargardt disease, offering hope for future ...

On the heels of its FDA approval, clinicians weigh in on acoltremon’s (Tryptry) novel mechanism of action and its potential ...

The ELEVATUM study explored faricimab's effectiveness in treating diabetic macular edema among underrepresented minorities, ...